Use of Oral Gonadotropin Releasing Hormone Antagonist Combinations for Preoperative Management of Refractory Leiomyoma-Related Heavy Menstrual Bleeding
Uterine leiomyomas are noncancerous smooth muscle neoplasms that occur in up to 70% of women and the single most common cause of hysterectomy. There is a variety of treatments available for uterine leiomyomas, including medications, uterine artery embolization, myomectomy, and hysterectomy but surgi...
Saved in:
| Main Authors: | Danielle A. Aase, Elizabeth A. Stewart |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mary Ann Liebert
2025-01-01
|
| Series: | Women's Health Reports |
| Subjects: | |
| Online Access: | https://www.liebertpub.com/doi/10.1089/whr.2025.0013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current approaches to the treatment of endometrial hyperplasia in women with uterine leiomyoma
by: Potapov V.A., et al.
Published: (2014-09-01) -
Ovarian sensitivity index affects clinical pregnancy and live birth rates in gonadotropin-releasing hormone agonist and antagonist in vitro fertilization cycles
by: Chao Chin Hsu, et al.
Published: (2024-12-01) -
LH level on trigger day, number of follicles ≥16 mm but <18 mm, and number of retrieved oocytes are independent risk factors for polyspermy in gonadotropin-releasing hormone antagonist protocol
by: Qiongyu Wu, et al.
Published: (2024-12-01) -
Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
by: Gulay Beydilli Nacak, et al.
Published: (2021-08-01) -
Efficacy and safety of degarelix in patients with prostate cancer: Results from a phase III study in China
by: Yinghao Sun, et al.
Published: (2020-07-01)